4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000032
Chief Operations Officer sold 3,416 shares at $3.09 ($10,541)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Johnston Lloyd P. Chief Operations Officer | 2022-01-05 | Sale | −3,416 | $3.09 | $10,541 | 175,299 | D: show line 1 in the form |
| Open-market sales · 3,416 sh · avg $3.09 · $10,541 | |||||||
Loading xslF345X03/wf-form4_164159027075368.xml…